Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with infection and co-existing inflammatory bowel disease
Objective To investigate the effect of sequential Helicobacter pylori eradication therapy on serum osteoprotegerin levels in patients with H. pylori infection and co-existing inflammatory bowel disease (IBD). Methods Three groups of patients were involved in this observational cross-sectional study:...
Guardado en:
Autores principales: | Hussam Murad, Misbahuddin Rafeeq, Mahmoud Mosli, Mamdouh Gari, Mohammed Basheikh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c194fbc0a7a345159d0029a4b2970c30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis
por: Murad H, et al.
Publicado: (2021) -
Effect of Lovastatin on Serum Osteoprotegerin Level in Type 2 Diabetic Nephropathy
por: N Nezami,, et al.
Publicado: (2012) -
Serum adropin levels are reduced in patients with inflammatory bowel diseases
por: Darko Brnić, et al.
Publicado: (2020) -
Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Christoph Kessel, et al.
Publicado: (2021) -
Significance of serum palmitoleic acid levels in inflammatory bowel disease
por: Yuko Akazawa, et al.
Publicado: (2021)